Download PDF
1 / Pages

Other users also viewed these articles

CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-¿B pathway Shuang Yang; Li Rong Peng; Ai Qing Yu; Jiang Li;
Ann Hepatol. 2023;28:
Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC Federico Piñero; Margarita Anders; Carla Bermudez; Ezequiel Demirdjian; Adriana Varón; Ana Palazzo; Jorge Rodriguez; Oscar Beltrán; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Pablo Caballini; Norberto Tamagnone; Virginia Reggiardo; Hugo Cheinquer; Alexandre Araujo; Diego Arufe; Juan Ignacio Marín; Natalia Ratusnu; Estela Manero; Daniela Perez; Marina Villa; Federico Orozco; Dolores Murga; Sebastián Marciano; Fernando Bessone; Marcelo Silva; Manuel Mendizabal;
Ann Hepatol. 2023;28:
Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective study Yongwu Chen; Xiuli Yang; Yanfei Shao; Hongying Zhao; Jinying Jiang; Ping Huang; Yi Lu; Zixue Xuan;
Ann Hepatol. 2023;28: